Status:
COMPLETED
Prevalence of Genetic Mutations in Patients With Neuropathy Associated With Anti-Myelin-associated Glycoprotein (MAG) Antibodies
Lead Sponsor:
Rennes University Hospital
Conditions:
Neuropathy Demyelinating
Eligibility:
All Genders
18+ years
Brief Summary
Anti-MAG (Myelin Associated Glycoprotein) neuropathy is related to clonal B lymphocyte proliferation producing an monoclonal immunoglobulin (IgM) with anti-MAG activity. IgM may be a reflection of mal...
Detailed Description
This is a retrospective observational study in patients with anti-MAG neuropathy. Mutational analysis will be performed for patients with a medullary or blood sample stored in a bio-bank during lympho...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients with anti-MAG neuropathy
- Blood and/or bone marrow samples available in bio-bank
- Given informed consent
- Exclusion criterion
- Participation refusal
Exclusion
Key Trial Info
Start Date :
October 21 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 10 2017
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT03268161
Start Date
October 21 2015
End Date
November 10 2017
Last Update
February 27 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rennes University Hospital
Rennes, France, 35000